Nathaniel Simons
Meritage Group
Nathaniel Simons CME Group Inc stake
total: 301
Meritage Group CME trades
- Total transactions:
- 4
- New positions:
- 2
- Sold out:
- 2
- Held since:
- 2022 Q4
- Held for:
- 1 quarter
- Latest activity:
- 2023 Q1
According to 2026 Q2 report, Nathaniel Simons doesn't hold any CME Group Inc (CME) shares. To date, the estimated cost basis is nearly $168.3 for "buy" trades and estimated average "sell" price is $168.3. Meritage Group first purchased CME in 2016 Q4, initially acquiring 10,307 shares. Nathaniel Simons later completely sold out the position and invested in CME Group Inc again in 2022 Q4. Since the initial investment in CME Group Inc (CME), Meritage Group has made 3 more transactions.
When did Nathaniel Simons sell CME Group Inc (CME)?
Nathaniel Simons sold off the entire CME Group Inc (CME) position in 2023 Q1.
When did Nathaniel Simons buy CME Group Inc (CME)?
Nathaniel Simons first invested in CME Group Inc (CME) in 2016 Q4 at the reported quarter-end price of $115.36 per share.
What's the cost basis of Meritage Group's CME stake?
The estimated cost basis for CME Group Inc (CME) stake is around $168.30 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $168.30
- Weighted AVG sell price:
- $168.30
Nathaniel Simons's historical trades in CME Group Inc
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2023 Q1
|
0.00%
|
0
|
$168.30
|
|
-100% (-1,325)
|
-0.01%
|
|
2022 Q4
|
0.01%
|
1,325
|
$168.30
|
$223,000
|
new
|
+0.01%
|
|
2017 Q1
|
0.00%
|
$115.36
|
-100% (-10,307)
|
|||
|
2016 Q4
|
0.04%
|
$115.36
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.